Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829848) titled 'Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic Therapy' on Sept. 15.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fudan University

Condition: Breast Cancer

Intervention: Radiation: standard boost

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: September 12, 2026

Target Sample Size: 534

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07829848

Published by HT Digital Con...